Hysterectomy vs. endometrial ablation for bleeding
Hysterectomy is more effective than endometrial ablation for arresting dysfunctional uterine bleeding without any additional intervention. But it's also associated with more adverse events. This according to the STOP-DUB (Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding) study, a randomized controlled trial.
Researchers followed 237 women, most younger than 45 years. At 24 months, endometrial ablation was slightly less effective than hysterectomy (84.9% vs. 94.4%) at solving the problem that led the women to seek care, and by 48 months, one third of the women initially receiving endometrial ablation required reoperation.
On the flip side, almost four times as many adverse events were reported in the group of women receiving hysterectomy as there were in the group of women receiving endometrial ablation, and there were almost six times as many postoperative infections.
Dickersin K, Munro MG, Clark M, et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstet Gynecol. 2007;110:1279-1289.
MORE ARTICLES IN THIS ISSUE
Daily oral intake of 70 mg of the soy isoflavone extract Phytosoya for 12 months is safe for the endometrium, according to the results of a study involving 395 postmenopausal women. The results suggest that the agent is a safe alternative or supplement to hormone therapy for the amelioration of climacteric symptoms.
Paclitaxel plus bevacizumab increases progression-free survival but not overall survival compared with paclitaxel alone in patients with metastatic breast cancer, researchers report in the Dec. 27 issue of the New England Journal of Medicine.
In patients with invasive cervical cancer, the most common sentinel node locations are external iliac, obturator and parametrium, according to a study published in the December issue of the American Journal of Obstetrics and Gynecology.
While uterine artery embolization (UAE) results in fewer complications than hysterectomy (19% vs. 26%, respectively, P=0.001), fewer women undergoing UAE report relief from fibroid symptoms (85% vs. 95%, P<0.0001), fewer report feeling better (84% vs. 96%, P<0.0001), and the women receiving UAE are more likely to require further treatment for fibroid symptoms. That's the conclusion of a British multi-center retrospective study comparing hysterectomy and UAE for the treatment of symptomatic uterine fibroids. Additional results: 3.9% of women required a hysterectomy in the first year after UAE and an additional 7.4% required a hysterectomy during years 2 through 7 after UAE.
Screening with annual transvaginal ultrasound (TVU) and CA125 is ineffective at detecting early-stage ovarian cancer in both high- and low-risk women, according to the findings of a retrospective audit study involving 341 asymptomatic women.